Introduction {#s1}
============

Asthma is a major public health issue. In the United States alone, it affects 6.2 million children and 13.8 million adults, and is a significant cause of morbidity and mortality [@pone.0010134-Moorman1]. Globally, it affects an estimated 300 million people, and is responsible for approximately 1 out of every 250 deaths[@pone.0010134-Masoli1]. Especially troubling is that it has increased significantly in the past 2--3 decades in the U.S. and worldwide [@pone.0010134-Cohn1], [@pone.0010134-Anandan1]. Reasons for this increase are not clear, however may reflect increased exposure to environmental risk factors.

Human epidemiologic studies have attempted to elucidate risk factors for disease. Many, but not all, of these studies have supported the common clinical perception that maternal asthma is associated with increased asthma risk in offspring, as compared to paternal asthma. These studies have varied in design, population composition, asthma definitions and size. Although most experts would agree that maternal asthma is a risk factor for offspring asthma, because of the differences in study design, it is difficult to determine if the magnitude of this 'maternal effect' is greater than the 'paternal effect.' Therefore, we screened the medical literature and performed a meta-analysis to examine the effect of maternal asthma on offspring asthma susceptibility.

Determination of the magnitude of this effect is important, as it may have broad implications in asthma pathogenesis. If maternal asthma does confer greater asthma risk to offspring than do paternal or parental asthma, then it implies that *in utero* and/or post-natal non-genetic factors can contribute to asthma susceptibility. If *in utero* and/or post-natal exposures can affect asthma initiation, then prevention of asthma becomes a possibility. This also opens new avenues for scientific investigation into the mechanisms underlying asthma susceptibility.

Methods {#s2}
=======

Ethics {#s2a}
------

No ethical approval was required.

Searching {#s2b}
---------

A search of the PubMed database was performed in an attempt to identify all studies that examined maternal and paternal asthma as a risk factor for offspring asthma. Records were searched from January 1966 to September 2009. Search headings used were 'asthma' and 'epidemiology'. The titles and abstracts of the articles were then manually scanned to determine relevant studies with information on risk for asthma in offspring of mothers and fathers with asthma. These articles were then retrieved ([Figure 1](#pone-0010134-g001){ref-type="fig"}). Bibliographies of pertinent articles and reviews were searched for additional references. The meta-analysis was performed according to the PRISMA guidelines ([Table S1](#pone.0010134.s001){ref-type="supplementary-material"}, [Figure S1](#pone.0010134.s002){ref-type="supplementary-material"}).

![Flow diagram of study selection for the meta-analyses.\
\*see text for details of excluded studies.](pone.0010134.g001){#pone-0010134-g001}

Selection {#s2c}
---------

Inclusion criteria: We included case-control and cross-sectional studies that examined asthma risk in offspring of asthmatic mothers and fathers. Offspring asthma was defined by a physician\'s diagnosis or questionnaire (self-reported asthma, recurrent wheeze, asthma symptoms). Exclusion criteria: 1) Repeated data sets. In a case where different studies used the same database, the more current study was used. 2) Diagnosis of asthma at \<1 year of age only. 3) Studies that defined asthma simply as any episode of wheeze. 4) Studies that did not contain both maternal and paternal asthma data. 5) Data that was not compatible with meta-analysis (prevalence rates, relative risks, and regression). We used odds ratios and if they were not available or derivable from the paper, the study was excluded.

Validity Assessment {#s2d}
-------------------

The study quality was assessed using the following questions. 1) Was asthma diagnosed by a physician? 2) Were the patients in the study \>/ = 5 years old? 3) Was the study a population based or case-control study? 4) Did the study control for ethnicity?

Studies using physician diagnosis as their definition for asthma were considered higher quality studies. Studies using other definitions (i.e. self-reported physician diagnosed asthma, self-reported asthma, self-reported recurrent/persistent wheeze, and self-reported recurrent asthma symptoms; or a combination of these measures) were deemed lower quality. If a study used a combination of definitions (i.e. physician diagnosed asthma or asthma symptoms), the quality of the study was based on the lesser definition. Studies where patients were \>/ = 5 years old were considered higher quality as compared to those where patients were \<5 years old. This quality measure was used as not all who wheeze as infants/toddlers go on to be diagnosed with asthma. An older patient population implies that the asthma diagnosis is more accurate. Population based studies were deemed higher quality than case-control studies. Studies which controlled for ethnicity were deemed higher quality than those that did not.

Data Abstraction {#s2e}
----------------

Two investigators independently searched and evaluated studies for inclusion (RHL, MD). Resulting lists were compared. Disagreements were resolved by discussions between RHL and MD. When discussions did not resolve disagreements, a third author (LK) was included.

Study Characteristics {#s2f}
---------------------

[Table 1](#pone-0010134-t001){ref-type="table"} summarizes the characteristics of the studies included in the analysis. Heterogeneity among the studies was assessed using the Q-statistic. Included studies were case-control and cohort studies using the categorical outcome of asthma (physician diagnosis, self report of physician diagnosis, or self report) and recurrent wheeze.
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###### Studies examining risk of asthma in offspring from asthmatic mothers and fathers.

![](pone.0010134.t001){#pone-0010134-t001-1}

                                                                       Offspring                   Adjusted risk estimate  
  --------------------- ------ -------------- -------- ------------------------------------------ ------------------------ ------
  Dold (8)               1992     Germany       4447      Quest MD asthma or recurrent wheeze             9 to 11           None
  Frischer (12)          1993     Germany       1812                Quest MD asthma                        7 to 8           Yes
  Kelly (16)             1995        UK         3746                Quest MD asthma                       5 to 11           Yes
  Abramson (36)          1996    Australia      675                Current MD ashtma                      20 to 44          None
  Ehrlich (10)           1996     S.Africa      620           Quest current asthma/wheeze                  7 to 9           None
  BaezaBacab (37)        1997      Mexico       505                 Quest MD asthma                       6 to 12           None
  Rona (28)              1997   UK, Scotland   11924    Quest asthma attack or persistent wheeze          5 to 11           Yes
  Jenkins (23)           1997    Australia     26718    Quest asthma attack or wheezy breathing           0 to 32           None
  Litonjua (17)          1998       USA         740                 Quest MD asthma                       1 to 24           Yes
  Millar (38)            1998      Canada      22433                  Quest asthma                        0 to 11           Yes
  Halonen (33)           1999       USA         1246                Quest MD asthma                          6              None
  Illi (21)              2001     Germany       939                Current MD Asthma                         7              Yes
  Wang (19)              2001      Taiwan       414           Quest MD asthma and symptoms                11 to 16          Yes
  Sherriff (30)          2001        UK         1536            Quest persistent wheeze                     3.5             Yes
  Wickens (20)           2001   New Zealand     474          Quest MD asthma and medicines                 7 to 9           Yes
  Karunasekera (24)      2001    Sri Lanka      600                    MD asthma                          1 to 10           Yes
  Jaakkola (22)          2001      Norway       2531          Quest MD asthma and symptoms                   4              Yes
  El-Sharif (35)         2003    Palestine      351                    MD asthma                          6 to 12           None
  Cole Johnson (32)      2004       USA         222                Current MD asthma                       6 to 7           Yes
  Sandin (29)            2004      Sweden       719             Quest persistent wheeze                      4              Yes
  Jan (14)               2004      Taiwan       2076          Quest MD asthma or symptoms                18 to \>65         Yes
  Arshad (34)            2005        UK         1373            Quest asthma and wheeze                      10             Yes
  Taveras (31)           2006       USA         1101            Quest persistent wheeze                      2              Yes
  De Sario (7)           2006      Italy        1674            Quest persistent wheeze                   9 to 11           Yes
  Lee (25)               2006      Taiwan      24784                  Quest asthma                        26 to 50          Yes
  Elizur (11)            2007      Israel        91       Quest asthma and lung function tests            6 to 40           None
  Bjerg (6)              2007      Sweden       3430               Current MD asthma                       7 to 8           Yes
  Mai (26)               2007      Canada       723                    MD asthma                          8 to 10           None
  Morais-Almeida (18)    2007     Portugal      249                 Recurrent wheeze                      8 to 14           Yes
  Martel (27)            2008      Canada      109746           MD asthma and medicines                      10             Yes
  Jacobson (13)          2008       USA         517          Quest MD asthma and medicines                4 (mean)          Yes
  Dong (9)               2008      China       16789                Quest MD asthma                       2 to 13           Yes
  Karino (15)            2008      Japan        9615                  Quest asthma                        18 to 20          Yes

In the Jan study asthma included probable asthmatics. In the Sheriff and Martel studies maternal asthma was asthma during pregnancy, while paternal asthma was defined by medical history. In the Johnson study parental asthma included hay fever and allergies. Medical doctor (MD) asthma  =  physician-diagnosed asthma. Quest MD asthma  =  physician-diagnosed asthma on questionnaire or by parents report.

Data Analysis {#s2g}
-------------

Meta-analyses were performed using the MIX program version 1.7 [@pone.0010134-Bax1]. Data from studies with dichotomous asthma outcomes were combined to give a summary odds ratio using the inverse variance method. Depending on the test for heterogeneity among the studies, we used a fixed-effects model or a random-effect model for the meta-analysis. Funnel plots and Egger\'s regression test were used to search for publication bias. Subgroup analyses were used to examine three potentially important sources of heterogeneity. The predetermined subgroups were based on asthma definition, the age of offspring, and study design. The stability of the summary risk estimate was evaluated using a sensitivity analysis in which each study was individually removed and the odds ratio was recalculated. Removal of each individual study did not significantly alter the summary odds ratio for offspring asthma in maternal asthma (range of recalculated summary odds ratio: 2.82 to 3.12) or paternal asthma (range of recalculated summary odds ratios: 2.36 to 2.53). The summary odds ratios for offspring asthma in maternal and paternal asthma were compared as described [@pone.0010134-Altman1].

Results {#s3}
=======

The initial Pubmed search using search headings 'asthma' and 'epidemiology' resulted in approximately 15,000 journal articles. Based on the titles 1,060 were potentially relevant, of which 235 were targeted for retrieval after review of the abstracts ([Figure 1](#pone-0010134-g001){ref-type="fig"}). One study was unavailable for retrieval [@pone.0010134-Majeed1], thus 234 total articles were subjected to detailed review. The 33 studies [@pone.0010134-Bjerg1]--[@pone.0010134-Millar1] included in the meta-analysis are listed in [Table 1](#pone-0010134-t001){ref-type="table"}.

Of the 234 papers retrieved for detailed evaluation, a total of 201 were excluded. 155 were excluded for lack of useable information. 11 were excluded because they were reviews [@pone.0010134-Barrett1]--[@pone.0010134-Wong1]. An additional 35 studies were excluded for reasons summarized in [figure 1](#pone-0010134-g001){ref-type="fig"} [@pone.0010134-Balemans1]--[@pone.0010134-Raby1]. The 4 studies that were removed due to 'incompatible data' did not use odds ratios, nor were they derivable from the data presented [@pone.0010134-Ball1]--[@pone.0010134-Raby1]. The remaining 33 were used for meta-analysis.

Study Quality {#s3a}
-------------

[Table 1](#pone-0010134-t001){ref-type="table"} lists the characteristics of the 33 papers. In 18 studies, asthma was physician diagnosed based on questionnaire [@pone.0010134-Bjerg1], [@pone.0010134-Dong1], [@pone.0010134-Frischer1], [@pone.0010134-Jacobson1], [@pone.0010134-Kelly1], [@pone.0010134-Litonjua1], [@pone.0010134-Wang1]--[@pone.0010134-Jaakkola1], [@pone.0010134-Karunasekera1], [@pone.0010134-Mai1], [@pone.0010134-Martel1], [@pone.0010134-ColeJohnson1], [@pone.0010134-Halonen1], [@pone.0010134-ElSharif1]--[@pone.0010134-BaezaBacab1]. In 7 studies asthma diagnosis was based on questionnaire, but not specifically physician diagnosed [@pone.0010134-Ehrlich1], [@pone.0010134-Elizur1], [@pone.0010134-Jan1], [@pone.0010134-Karino1], [@pone.0010134-Jenkins1], [@pone.0010134-Lee1], [@pone.0010134-Millar1]. In 6 studies, recurrent/persistent wheeze was used as a surrogate for asthma [@pone.0010134-DeSario1], [@pone.0010134-Dold1], [@pone.0010134-MoraisAlmeida1], [@pone.0010134-Rona1]--[@pone.0010134-Sherriff1]. Of the 7 studies with non-physician diagnosed asthma, 1 included recurrent wheeze [@pone.0010134-Rona1] in its asthma definition, and 1 included "wheezy" breathing [@pone.0010134-Jenkins1]. Of the 33 studies used in this meta-analysis, 8 included patients less than 5 years of age at time of the study [@pone.0010134-Dong1], [@pone.0010134-Jacobson1], [@pone.0010134-Litonjua1], [@pone.0010134-MoraisAlmeida1], [@pone.0010134-Karunasekera1], [@pone.0010134-Sherriff1], [@pone.0010134-Taveras1], [@pone.0010134-Millar1]. Of the 33 studies used in the meta-analysis, 25 were population based [@pone.0010134-Bjerg1]--[@pone.0010134-Dong1], [@pone.0010134-Elizur1]--[@pone.0010134-MoraisAlmeida1], [@pone.0010134-Illi1]--[@pone.0010134-Jenkins1], [@pone.0010134-Lee1], [@pone.0010134-Rona1]--[@pone.0010134-Halonen1], [@pone.0010134-BaezaBacab1], [@pone.0010134-Millar1], [@pone.0010134-Arshad2] and 8 were case-control studies [@pone.0010134-Ehrlich1], [@pone.0010134-Wang1], [@pone.0010134-Wickens1], [@pone.0010134-Karunasekera1], [@pone.0010134-Mai1], [@pone.0010134-Martel1], [@pone.0010134-ElSharif1], [@pone.0010134-Abramson1].

Although asthma epidemiology can vary based on ethnicity[@pone.0010134-Moorman1], [@pone.0010134-Saxena1]--[@pone.0010134-Forno1], there is no direct evidence that ethnicity confounds a potential relationship between maternal/paternal and offspring asthma. However, ethnicity could confound our data, if couples were unbalanced on this convariate. Of the 33 studies, 9 were conducted in the North America, 8 in Europe, 1 in Africa, 2 in Australia, 1 in New Zealand, 6 in Asia, 4 in the U.K., and 2 in the Middle East ([Table 1](#pone-0010134-t001){ref-type="table"}). Ethnic diversity was presumed to be less in populations from countries other than North America and the U.K.

Of the studies used in this meta-analysis, only 3 fulfilled all 4 predetermined quality criteria [@pone.0010134-Bjerg1], [@pone.0010134-Frischer1], [@pone.0010134-Illi1]. The most common reason was lack of physician diagnosis.

Maternal asthma and offspring asthma {#s3b}
------------------------------------

The pooled analysis for the 33 total studies is summarized in [figure 2](#pone-0010134-g002){ref-type="fig"}. Children of asthmatic mothers are more likely than children of non-asthmatic mothers to develop asthma (summary OR 3.04, 95% CI: 2.59--3.56). The test for heterogeneity showed a non-significant p-value of 0.13, indicating that the studies had similar outcomes and were appropriate to be summarized in a meta-analysis. The funnel plot of OR versus standard error was symmetric ([Figure S2](#pone.0010134.s003){ref-type="supplementary-material"}), and Egger\'s test was negative for publication bias (p = 0.38). To ensure that no single study skewed the overall results, each study was removed one at a time and the summary OR recalculated. Removal of each individual study did not significantly alter the summary OR. All the recalculated summary odds ratios lay within the 95% confidence interval of the principal analysis (range of recalculated summary odds ratio: 2.82 to 3.12).

![Studies of maternal asthma as a risk factor of asthma.\
Sizes of boxes represent inverse variance weights (random effects model). Lines represent 95% confidence intervals.](pone.0010134.g002){#pone-0010134-g002}

Subgroup analysis was also performed based on quality measures. When analyzing only those papers which were based on physician diagnosed asthma (including self-report physician diagnosed asthma) (N = 18) similar but attenuated results were seen 2.85 (2.30--3.54). When analyzing those studies where the patient population was \>/ = 5 year of age (N = 25) or those which were population based (N = 25) the summary OR was similar but elevated at 3.15 (2.53--3.93) and 3.41 (2.87--4.06) respectively.

We also analyzed only those studies that adjusted for potential confounding and those studies where the patient population were adults (age \>/ = 18 years). When analyzing those studies that adjusted for potential confounding (N = 24) or those where the patient population was \>/ = 18 year of age (N = 4) similar but elevated summary OR were seen (3.34 (2.69--4.14) and 5.33 (2.51--11.3) respectively).

Paternal asthma and offspring asthma {#s3c}
------------------------------------

Similar analysis was performed on the paternal asthma data. The analysis is summarized in [figure 3](#pone-0010134-g003){ref-type="fig"}. Children of asthmatic fathers are more likely to develop asthma than those of non-asthmatic fathers (summary OR 2.44, 95%CI: 2.14--2.79). The test for heterogeneity showed a non-significant p-value of 0.06. The funnel plot of OR versus standard error was symmetric ([Figure S3](#pone.0010134.s004){ref-type="supplementary-material"}), and Egger\'s test was negative for publication bias (p = 0.50). To ensure that no single study skewed the overall results, each study was removed one at a time and summary OR recalculated. Removal of each individual study did not significantly alter the summary OR (range of recalculated summary odds ratios: 2.36 to 2.53).

![Studies of paternal asthma as a risk factor of asthma.\
Sizes of boxes represent inverse variance weights (random effects model). Lines represent 95% confidence intervals.](pone.0010134.g003){#pone-0010134-g003}

Subgroup analysis was also performed in the same groups as were used in the maternal asthma data. When analyzing only those papers which were based on physician diagnosed asthma (N = 18) similar results were seen 2.48 (2.01--3.06). When analyzing those studies where the patient population was \>/ = 5 year of age (N = 25) or those which were population based (N = 25) the summary OR was similar but elevated at 2.60 (2.28--2.96) and 2.56 (2.19--2.98) respectively; Heterogeneity was possible in the former subgroup analysis as p = 0.02.

When analyzing those studies that adjusted for potential confounding (N = 24) or those where the patient population was \>/ = 18 year of age (N = 4) similar but elevated summary odds ratio were seen (2.39 (2.04--2.80) and 2.72 (2.03--3.65) respectively).

Maternal versus Paternal Effect {#s3d}
-------------------------------

The data show that both maternal and paternal disease state affects offspring disease, and based on individual studies, maternal asthma is the more potent contributor. When analyzing all studies and comparing the two summary odds ratios, maternal asthma confers greater risk of disease than does paternal asthma (OR 3.04 and 2.44, respectively, p = 0.037). Similar trends were seen using subgroup analysis, although the differences did not achieve statistical significance for all analyses. For example, in analyzing the studies in which the patient population was \>/ = 5 yo the odds ratios were 3.15 and 2.60, maternal versus paternal asthma respectively (p = 0.14). Similarly in analysis of the studies in which asthma was diagnosed by a physician the odds ratios were 2.85 and 2.48, maternal versus paternal asthma respectively (p = 0.37). When analyzing the studies which were population based the difference remained, with odds ratios of 3.41 and 2.56, maternal versus paternal respectively (p = 0.02).

We also analyzed those studies which adjusted for potential confounding and those studies where the patient population were adults (\>/ = 18 years). Analyzing the studies which adjusted for confounders the odds ratios were 3.34 and 2.39, maternal versus paternal respectively (p = 0.01). When analyzing the studies where the patient population was \>/ = 18 years the odds ratios were 5.33 versus 2.72, maternal versus paternal respectively (p = 0.10).

Discussion {#s4}
==========

To investigate the role of maternal asthma in offspring asthma, we performed a meta-analysis of multiple studies to determine if a parent of origin effect exists. In our meta-analysis of 33 studies, maternal asthma predisposes offspring to disease more so than paternal asthma. This effect is modest (OR 3.04 versus 2.44), but statistically significant. This demonstrates that non-genetic *in utero* and/or post-natal factors may play a significant role in the transmission of asthma susceptibility. How these factors could induce asthma susceptibility has not been elucidated. However, animal models have demonstrated the potential for transplacental passage of 'pro-asthmatic' mediators (e.g. Th2 cytokines, immunologic cells, etc.), which could theoretically be capable of modifying the developing fetal immune system \[reviewed [@pone.0010134-Lim1]\]. Alternatively, or in addition to, it is possible that post-natal exposures such as maternal breast milk could shape the developing immune system. Murine models have demonstrated that breast milk from asthmatic mothers can induce asthma susceptibility in offspring [@pone.0010134-Leme1]. Human studies have also demonstrated that breast feeding can affect offspring asthma/lung function [@pone.0010134-Guilbert1], [@pone.0010134-Wright1]. The mechanisms for the phenomenon demonstrated in this meta-analysis require further study using animal models.

When analyzing the studies in which asthma was diagnosed by a physician, in studies which were population based or in studies with a patient population \>/ = 5 years of age, the maternal effect remained more prominent than the paternal effect, though the magnitude of the difference was attenuated for some analyses. The subgroup analyses had fewer individuals and thus reduced power in comparison to the overall analysis. When analysing smaller subgroups subsequent to the principal analysis the chance of spurious findings may increase. Had more studies fit the quality criteria, then the differences may not have been attenuated. There were also potential confounding factors for this analysis that were not considered. These are discussed below.

This meta-analysis has several drawbacks that warrant discussion. There are multiple known risk factors for asthma, which this meta-analysis did not control for. For example, both *in utero* and *ex utero* exposure to tobacco smoke can increase the risk of wheezing/asthma [@pone.0010134-Pattenden1], [@pone.0010134-Keil1], [@pone.0010134-Lannero1]. Lower socioeconomic status is also associated with increased asthma susceptibility [@pone.0010134-Kozyrskyj1], [@pone.0010134-Akinbami1]. In addition, breasting feeding can affect asthma risk and lung function depending on timing and maternal disease status [@pone.0010134-Guilbert1], [@pone.0010134-Wright1]. This meta-analysis did not exclude studies that did not control for such exposures, nor was it used as quality criteria. This was because few studies controlled for such exposures. Exposure to such factors is likely to happen independent of maternal or paternal disease status. Therefore, inclusion of these studies would make it less likely to discover a significant difference between maternal and paternal asthma. Despite this, the overall summary OR of this study demonstrated that maternal asthma, more so than paternal asthma, is a significant risk factor for offspring asthma. The inclusion of studies that did not control for exposures to asthma risk factors may explain in part why the trend was preserved in subgroup analysis, but lost statistical significance.

It should also be noted that 4 retrieved studies were not used in this analysis because their data was not compatible with our meta-analysis. Of the four papers, two showed a greater role for paternal asthma versus maternal asthma in offspring asthma risk [@pone.0010134-Ly1], [@pone.0010134-Raby1]. As these papers used regression, it is difficult to extrapolate how they would have affected the analysis were their data able to be included.

A common problem in meta-analysis is publication bias. Based on Eggers test and a symmetrical funnel plot, this study is free from publication bias. Also, for most of the studies used in this paper, the finding that maternal asthma conferred greater risk to offspring was not the primary endpoint. This further decreased the likelihood of publication bias.

Based on this meta-analysis, maternal asthma increases offspring disease risk to a greater extent than paternal disease. This can be interpreted to mean that the increased asthma risk conferred by maternal disease is not due solely to genetic inheritance. These findings are consistent with experimental studies demonstrating that maternal asthma/exposures in animal models can induce asthma susceptibility in offspring [@pone.0010134-Leme1], [@pone.0010134-Fedulov1]--[@pone.0010134-Lim2], and support the need for further work in elucidating the mechanisms for the 'maternal effect.'
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Funnel plot of studies examining asthma risk in offspring of asthmatic versus non-asthmatic mothers. Individual risk estimates for each study are superimposed on lines representing the summary odds ratio (center) and pseudo 95% confidence limits. There is no evidence of bias in the formal plot or by Eggers test.

(0.03 MB PDF)

###### 

Click here for additional data file.

###### 

Funnel plot of studies examining asthma risk in offspring of asthmatic versus non-asthmatic fathers. Individual risk estimates for each study are superimposed on lines representing the summary odds ratio (center) and pseudo 95% confidence limits. There is no evidence of bias in the formal plot or by Eggers test.
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